Tendons are notoriously slow to heal because they barely have a blood supply, so it was striking when researchers cut a rat's Achilles tendon clean through, gave it BPC-157, and described a full recovery "the reestablishment of full tendon integrity." Again, in a rat [5]
The body produces new red blood cells within 48 to 72 hours after the shot
The reduced expression of IGF2BP3 in the villous tissues of RM patients correlated with a decrease in mRNA stability of GPX4, thereby promoting ferroptosis and hindering trophoblast invasion
What the evidence supports: BPC-157 consistently improves tendon healing outcomes in animal models across multiple tissue types and injury models TB-500 accelerates wound healing and tissue repair in preclinical studies with measurable improvements in re-epithelialization, collagen deposition, and angiogenesis GHK-Cu enhances collagen synthesis and modulates thousands of genes involved in tissue repair GHRP-2 shifts macrophage polarization favorably in a rotator cuff tear model Relaxin-2 eliminates capsular fibrosis in a frozen shoulder mouse model No significant toxicity has been identified in preclinical BPC-157 studies What remains uncertain: Whether animal study results translate to equivalent human outcomes for shoulder conditions specifically Optimal dosing for human shoulder injuries (all protocols are extrapolated from animal data and clinical observation) Long-term safety with repeated use Whether peptides meaningfully reduce rotator cuff retear rates after surgical repair in humans How peptide therapy compares to established treatments like PRP in controlled human studies Potential interactions with medications commonly used by shoulder pain patients What we need: Randomized controlled trials of BPC-157 and TB-500 for specific shoulder conditions in humans Head-to-head comparisons of peptide therapy versus established treatments Long-term safety data from monitored human use Standardized dosing protocols based on human pharmacokinetic data Studies combining peptides with rehabilitation to assess synergistic effects The preclinical evidence is compelling
By supporting a healthy balance of these signals, glutathione may help the body maintain a more stable, less reactive state
